Development of chitosan/polyethylene vinyl acetate co-matrix: Controlled release of aspirin-heparin for preventing cardiovascular thrombosis

Simple item page
dc.contributorVasudev, SC
dc.contributorChandy, T
dc.contributorSharma, CP
dc.date.accessioned2012-12-04T11:43:49Z
dc.date.available2012-12-04T11:43:49Z
dc.date.issued1997
dc.description.abstractAspirin and heparin were embedded in chitosan/polyethylene vinyl acetate co-matrix to develop a prolonged release form. The in vitro release profiles of these drugs from the co-matrix system were monitored in Tris HCl buffer pH 7.4, using a UV spectrophotometer. The amount of drug release was initially much higher, followed by a constant slow release profile for a prolonged period. The initial burst release was substantially modified with styrenebutadiene coatings. From scanning electron microscopy studies it appears that the drugs diffuse out slowly to the dissolution medium through the micropores of the co-matrix. The released aspirin-heparin from the co-matrix system had shown their antiplatelet and anticoagulant functions. The results propose the possibility of delivering drug combinations, having synergestic effects for therapeutic applications. (C) 1997 Elsevier Science Limited. All rights reserved.
dc.identifier.citationBIOMATERIALS. 18; 5; 375-381en_US
dc.identifier.urihttp://dx.doi.org/10.1016/S0142-9612(96)00131-7
dc.identifier.urihttps://dspace.sctimst.ac.in/handle/123456789/345
dc.publisherBIOMATERIALS
dc.subjectDrug Delivery
dc.titleDevelopment of chitosan/polyethylene vinyl acetate co-matrix: Controlled release of aspirin-heparin for preventing cardiovascular thrombosis
Files
Collections
Journal Articles